List of conversion stocks (part 3) [Parabolic Cigna Corp conversion stocks list]

○ List of stocks converted to Sell Market Code Stock Name Closing Price SAR Main Board <3837> Adsol 1056 1119 <3864> Mitsubishi Paper 685707 <3877> Chuetsu Pulp 14571520 <3880> Daio Paper 831881 <3925> D Standard 15251598 <3937> Ubicom 13421418 <3941> Rengo 817841 <3946> Tomoku

Fisco JapanMar 30 18:54 ET

Chinese Biotech Ascentage Pharma's Valuation Driven By Late-Stage De-Risked Assets: JPMorgan

BenzingaMar 27 15:04 ET

Mirum Pharmaceuticals Says Livmarli Approved in Japan for Pruritus

MT NewswiresMar 27 09:39 ET

Express News | Takeda's HyQvia Receives Expanded Market Authorization From Health Canada

BenzingaMar 27 09:32 ET

Takeda Pharmaceutical To Go Ex-Dividend On March 28th, 2025 With 98 JPY Dividend Per Share

March 27th (Japan Standard Time) - $Takeda Pharmaceutical(4502.JP)$ is trading ex-dividend on March 28th, 2025.Shareholders of record on March 31st, 2025 will receive 98 JPY dividend per share. The

Moomoo NewsMar 26 21:00 ET

Regarding the application for partial change in manufacturing and marketing approval for the treatment of congenital thrombotic thrombocytopenic purpura "Ajinma intravenous injection 1500" (apadama terase alpha (recombinant) / sinakizada mu terase alpha (

Regarding the partial change in the approval for the manufacture and sale application to expand the indication of "Aginma Injection 1500" (Apadomate Alpha (recombinant) / Sinacasadamate Alpha (recombinant)) for children under 12 years old - March 27, 2025 - Congenital Thrombotic Thrombocytopenic Purpura (cTTP) is an extremely rare blood coagulation disorder characterized by life-threatening acute symptoms and chronic, debilitating symptoms - "Aginma Injection 1500".

Takeda PharmaceuticalMar 26 11:00 ET